New York State Common Retirement Fund Buys 3,000 Shares of TESARO Inc (TSRO)

New York State Common Retirement Fund grew its stake in shares of TESARO Inc (NASDAQ:TSRO) by 2.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 107,497 shares of the biopharmaceutical company’s stock after acquiring an additional 3,000 shares during the period. New York State Common Retirement Fund owned about 0.20% of TESARO worth $13,878,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. BlackRock Inc. raised its stake in TESARO by 5.7% during the 2nd quarter. BlackRock Inc. now owns 3,605,247 shares of the biopharmaceutical company’s stock valued at $504,230,000 after purchasing an additional 195,590 shares during the period. Vanguard Group Inc. raised its stake in TESARO by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 2,978,236 shares of the biopharmaceutical company’s stock valued at $416,537,000 after purchasing an additional 62,104 shares during the period. State Street Corp raised its stake in TESARO by 17.9% during the 2nd quarter. State Street Corp now owns 1,168,913 shares of the biopharmaceutical company’s stock valued at $163,496,000 after purchasing an additional 177,057 shares during the period. BB Biotech AG raised its stake in TESARO by 6.5% during the 2nd quarter. BB Biotech AG now owns 877,990 shares of the biopharmaceutical company’s stock valued at $122,796,000 after purchasing an additional 53,408 shares during the period. Finally, Janus Henderson Group PLC acquired a new stake in TESARO during the 2nd quarter valued at $100,301,000.

TESARO Inc (TSRO) opened at $80.58 on Monday. The company has a quick ratio of 4.35, a current ratio of 4.73 and a debt-to-equity ratio of 0.34. TESARO Inc has a 1 year low of $77.20 and a 1 year high of $192.94.

TESARO (NASDAQ:TSRO) last posted its earnings results on Tuesday, November 7th. The biopharmaceutical company reported ($0.47) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.16) by $0.69. The firm had revenue of $142.77 million for the quarter, compared to the consensus estimate of $130.57 million. TESARO had a negative net margin of 251.22% and a negative return on equity of 93.39%. The business’s quarterly revenue was up 740.3% on a year-over-year basis. During the same period in the prior year, the business posted ($1.72) earnings per share. equities analysts expect that TESARO Inc will post -8.17 earnings per share for the current year.

Several analysts have issued reports on the stock. Robert W. Baird reissued a “neutral” rating and set a $125.00 target price on shares of TESARO in a research note on Monday, October 2nd. Cann reissued a “buy” rating and set a $199.00 target price on shares of TESARO in a research note on Friday, September 8th. BidaskClub raised shares of TESARO from a “strong sell” rating to a “sell” rating in a research note on Wednesday, August 23rd. Citigroup reaffirmed a “buy” rating and issued a $216.00 price target on shares of TESARO in a research note on Monday, September 11th. Finally, Oppenheimer reaffirmed a “buy” rating and issued a $199.00 price target on shares of TESARO in a research note on Sunday, September 10th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $159.39.

In other TESARO news, SVP Martin H. Jr. Huber sold 829 shares of the stock in a transaction on Monday, December 4th. The shares were sold at an average price of $85.24, for a total transaction of $70,663.96. Following the transaction, the senior vice president now directly owns 8,101 shares of the company’s stock, valued at $690,529.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Martin H. Jr. Huber sold 592 shares of the stock in a transaction on Friday, September 22nd. The stock was sold at an average price of $118.60, for a total transaction of $70,211.20. Following the transaction, the senior vice president now directly owns 6,943 shares in the company, valued at $823,439.80. The disclosure for this sale can be found here. Corporate insiders own 40.50% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://sportsperspectives.com/2017/12/18/new-york-state-common-retirement-fund-buys-3000-shares-of-tesaro-inc-tsro.html.

TESARO Profile

TESARO, Inc is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Institutional Ownership by Quarter for TESARO (NASDAQ:TSRO)

Receive News & Ratings for TESARO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TESARO and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply